Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
Gilles Montalescot(Maastricht University Medical Centre), Petr Widimský(Charles University), Jurriën M. ten Berg(St. Antonius Ziekenhuis), Christian W. Hamm(Justus-Liebig-Universität Gießen), Patrick Goldstein(Centre Hospitalier Universitaire de Lille), Paolo Angioli, Dariusz Dudek(Jagiellonian University), Johanne Silvain(Sorbonne Université), Zuzana Moťovská(Charles University), Jacek Legutko(John Paul II Hospital), Margit Niethammer, Éric Vicaut(Université Paris Cité), Guillaume Cayla(Université de Nîmes), Jean-François Tanguay(Montreal Heart Institute), Luigi Oltrona Visconti(Policlinico San Matteo Fondazione), Jochen Goedicke, Timothy M. Costigan(Eli Lilly (United States)), Leonardo Bolognese(Azienda Usl 8 Arezzo), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Debra L. Miller(University of Nottingham)
Cited by 651
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k